The news followed an investigation by POLITICO’s E&E News into climate-friendly inhalers and how drug giants are developing them to undermine competition. The pharmaceutical giant AstraZeneca has ...
The Biden administration has reformed Medicare, gone after bogus drug patents and pushed pharmaceutical companies to reduce inhaler costs for patients. “Climate-friendly inhalers” could jeopardize ...
July 25 (Reuters) - A panel of the European medicines regulator has recommended approving an eco-friendly version of AstraZeneca's (AZN.L), opens new tab inhaler for the treatment of a chronic lung ...
A bill passed by New York lawmakers on June 12 would eliminate out-of-pocket costs for asthma inhalers if signed by Governor ...
Medically reviewed by Susan Russell, MD Key Takeaways Inhaler colors often help identify the type of medication inside but ...
“Since I’ve been vice president, we have capped the cost of prescription medication for seniors at $2,000 a year.” The development of green inhalers jeopardizes those gains. Drug companies will be ...